Mass General Brigham Launches Two Cancer MRD Trials
August 7, 2025
Haystack Oncology, a Quest Diagnostics company, announced a research collaboration with Mass General Brigham investigators at Massachusetts Eye and Ear and Massachusetts General Hospital, world-renowned